Companies: 10,639     total market cap: S$173.218 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ
Neurocrine Biosciences
NBIX
#1388
Rank
S$19.74 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
S$198.01
Share price
-0.18%
Change (1 day)
10.39%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: S$19.74 Billion

As of December 2025 Neurocrine Biosciences has a market cap of S$19.74 Billion. This makes Neurocrine Biosciences the world's 1388th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025S$19.74 B2.88%
2024S$19.19 B12.24%
2023S$17.09 B11.07%
2022S$15.39 B40.92%
2021S$10.92 B-7.8%
2020S$11.84 B-11.4%
2019S$13.37 B50.96%
2018S$8.85 B-3.55%
2017S$9.18 B88.74%
2016S$4.86 B-29.51%
2015S$6.90 B205.81%
2014S$2.25 B183.21%
2013S$0.79 B31.13%
2012S$0.60 B-0.07%
2011S$0.60 B12.62%
2010S$0.54 B221.52%
2009S$0.16 B-4.9%
2008S$0.17 B-29.36%
2007S$0.25 B-58.72%
2006S$0.60 B-84.38%
2005S$3.87 B31.99%
2004S$2.93 B-10.2%
2003S$3.27 B34.7%
2002S$2.42 B-15.73%
2001S$2.88 B98.35%
2000S$1.45 B63.21%
1999S$0.89 B314.39%
1998S$0.21 B-8.5%
1997S$0.23 B-8.66%
1996S$0.25 B

End of Day market cap according to different sources

On Dec 15th, 2025 the market cap of Neurocrine Biosciences was reported to be:

S$19.77 Billion
by Nasdaq info icon info icon
S$19.77 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
S$11.45 B-41.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
S$28.80 B 45.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
S$62.95 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.226 T 6,111.08%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$511.01 B 2,488.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$187.52 B 849.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$2.37 B-87.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.07 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com